首页>
外国专利>
Overexpression of FOXC1 to treat corneal vascularization
Overexpression of FOXC1 to treat corneal vascularization
展开▼
机译:FoxC1的过度表达治疗角膜血管化
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed are methods and pharmaceutical compositions for treating and inhibiting conical vascularization including conical vascularization associated with viral infection, chemical injury, autoimmune conditions, and post-corneal transplantation or in subjects having a PAX6 mutation associated with conical vascularization. The methods and pharmaceutical compositions are utilized in administering treatment that results in increased concentration of FOXC1 in a subject's cornea in order to treat or inhibit corneal vascularization.
展开▼